4.5 Editorial Material

Is COVID-19 the Newest Comorbidity of Obesity Mitigated by Bariatric Surgery?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

The First Modified Delphi Consensus Statement for Resuming Bariatric and Metabolic Surgery in the COVID-19 Times

Sjaak Pouwels et al.

Summary: The study aimed to achieve consensus among global experts on various aspects of resuming Bariatric and Metabolic Surgery during the COVID-19 pandemic through a modified Delphi consensus-building protocol, presenting 38 key recommendations.

OBESITY SURGERY (2021)

Article Surgery

Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity The SLEEVEPASS Randomized Clinical Trial

Sofia Gronroos et al.

Summary: The study compared weight loss and quality of life improvement at 7 years after laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) in patients with morbid obesity. The results showed that LRYGB resulted in greater weight loss than LSG, but there was no significant difference in long-term quality of life between the two procedures.

JAMA SURGERY (2021)

Article Endocrinology & Metabolism

Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study

Min Gao et al.

Summary: The study found that above a BMI of 23 kg/m(2), there is a linear increase in the risk of severe consequences of COVID-19 leading to hospital admission and death, and a linear increase in ICU admission risk across the entire BMI range. The impact of increasing BMI is particularly notable in individuals younger than 40 years and of Black ethnicity.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Article Medicine, General & Internal

Association Between Bariatric Surgery and Long-term Survival

David E. Arterburn et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)